193 related articles for article (PubMed ID: 32464173)
21. Mouse induced pluripotent stem cells-derived Alzheimer's disease cerebral organoid culture and neural differentiation disorders.
Fan W; Sun Y; Shi Z; Wang H; Deng J
Neurosci Lett; 2019 Oct; 711():134433. PubMed ID: 31421155
[TBL] [Abstract][Full Text] [Related]
22. A simplified and sensitive method to identify Alzheimer's disease biomarker candidates using patient-derived induced pluripotent stem cells (iPSCs).
Shirotani K; Matsuo K; Ohtsuki S; Masuda T; Asai M; Kutoku Y; Ohsawa Y; Sunada Y; Kondo T; Inoue H; Iwata N
J Biochem; 2017 Dec; 162(6):391-394. PubMed ID: 28992104
[TBL] [Abstract][Full Text] [Related]
23. Opportunities and Limitations of Modelling Alzheimer's Disease with Induced Pluripotent Stem Cells.
Ovchinnikov DA; Wolvetang EJ
J Clin Med; 2014 Dec; 3(4):1357-72. PubMed ID: 26237606
[TBL] [Abstract][Full Text] [Related]
24. Important advances in Alzheimer's disease from the use of induced pluripotent stem cells.
Majolo F; Marinowic DR; Machado DC; Da Costa JC
J Biomed Sci; 2019 Feb; 26(1):15. PubMed ID: 30728025
[TBL] [Abstract][Full Text] [Related]
25. Human iPSC-Derived Neural Models for Studying Alzheimer's Disease: from Neural Stem Cells to Cerebral Organoids.
Barak M; Fedorova V; Pospisilova V; Raska J; Vochyanova S; Sedmik J; Hribkova H; Klimova H; Vanova T; Bohaciakova D
Stem Cell Rev Rep; 2022 Feb; 18(2):792-820. PubMed ID: 35107767
[TBL] [Abstract][Full Text] [Related]
26. Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.
Kondo T; Asai M; Tsukita K; Kutoku Y; Ohsawa Y; Sunada Y; Imamura K; Egawa N; Yahata N; Okita K; Takahashi K; Asaka I; Aoi T; Watanabe A; Watanabe K; Kadoya C; Nakano R; Watanabe D; Maruyama K; Hori O; Hibino S; Choshi T; Nakahata T; Hioki H; Kaneko T; Naitoh M; Yoshikawa K; Yamawaki S; Suzuki S; Hata R; Ueno S; Seki T; Kobayashi K; Toda T; Murakami K; Irie K; Klein WL; Mori H; Asada T; Takahashi R; Iwata N; Yamanaka S; Inoue H
Cell Stem Cell; 2013 Apr; 12(4):487-96. PubMed ID: 23434393
[TBL] [Abstract][Full Text] [Related]
27. Human Pluripotent Stem Cell-Derived Neural Cells as a Relevant Platform for Drug Screening in Alzheimer's Disease.
Garcia-Leon JA; Caceres-Palomo L; Sanchez-Mejias E; Mejias-Ortega M; Nuñez-Diaz C; Fernandez-Valenzuela JJ; Sanchez-Varo R; Davila JC; Vitorica J; Gutierrez A
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962164
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's in a dish - induced pluripotent stem cell-based disease modeling.
de Leeuw S; Tackenberg C
Transl Neurodegener; 2019; 8():21. PubMed ID: 31338163
[TBL] [Abstract][Full Text] [Related]
29. Induced Pluripotent Stem Cell-Derived Astroglia: A New Tool for Research Towards the Treatment of Alzheimer's Disease.
Atkinson-Dell R; Mohamet L
Adv Exp Med Biol; 2019; 1175():383-405. PubMed ID: 31583596
[TBL] [Abstract][Full Text] [Related]
30. 3D bioprinting patient-derived induced pluripotent stem cell models of Alzheimer's disease using a smart bioink.
Benwood C; Walters-Shumka J; Scheck K; Willerth SM
Bioelectron Med; 2023 May; 9(1):10. PubMed ID: 37221543
[TBL] [Abstract][Full Text] [Related]
31. Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.
Gohel D; Zhang P; Gupta AK; Li Y; Chiang CW; Li L; Hou Y; Pieper AA; Cummings J; Cheng F
J Alzheimers Dis; 2024; 98(2):643-657. PubMed ID: 38427489
[TBL] [Abstract][Full Text] [Related]
32. Human-Induced Pluripotent Stem Cell (hiPSC)-Derived Neurons and Glia for the Elucidation of Pathogenic Mechanisms in Alzheimer's Disease.
Young JE; Goldstein LSB
Methods Mol Biol; 2023; 2561():105-133. PubMed ID: 36399267
[TBL] [Abstract][Full Text] [Related]
33. Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models.
Sproul AA
Mol Aspects Med; 2015; 43-44():54-65. PubMed ID: 26101165
[TBL] [Abstract][Full Text] [Related]
34. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
Wu YY; Chiu FL; Yeh CS; Kuo HC
Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
[TBL] [Abstract][Full Text] [Related]
35. 3D culture models of Alzheimer's disease: a road map to a "cure-in-a-dish".
Choi SH; Kim YH; Quinti L; Tanzi RE; Kim DY
Mol Neurodegener; 2016 Dec; 11(1):75. PubMed ID: 27938410
[TBL] [Abstract][Full Text] [Related]
36. Self-Organizing 3D Human Neural Tissue Derived from Induced Pluripotent Stem Cells Recapitulate Alzheimer's Disease Phenotypes.
Raja WK; Mungenast AE; Lin YT; Ko T; Abdurrob F; Seo J; Tsai LH
PLoS One; 2016; 11(9):e0161969. PubMed ID: 27622770
[TBL] [Abstract][Full Text] [Related]
37. Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening.
Chang CY; Ting HC; Liu CA; Su HL; Chiou TW; Lin SZ; Harn HJ; Ho TJ
Molecules; 2020 Apr; 25(8):. PubMed ID: 32344649
[TBL] [Abstract][Full Text] [Related]
38. Increased susceptibility to Aβ toxicity in neuronal cultures derived from familial Alzheimer's disease (PSEN1-A246E) induced pluripotent stem cells.
Armijo E; Gonzalez C; Shahnawaz M; Flores A; Davis B; Soto C
Neurosci Lett; 2017 Feb; 639():74-81. PubMed ID: 28034781
[TBL] [Abstract][Full Text] [Related]
39. Stem cell models of Alzheimer's disease: progress and challenges.
Arber C; Lovejoy C; Wray S
Alzheimers Res Ther; 2017 Jun; 9(1):42. PubMed ID: 28610595
[TBL] [Abstract][Full Text] [Related]
40. [Modeling neurological and psychiatric disorders in vitro using induced pluripotent stem cells: highlighting findings in Alzheimer's disease and schizophrenia].
Hathy E; Kalman S; Apati A; Nemoda Z; Rethelyi JM
Neuropsychopharmacol Hung; 2016 Dec; 18(4):188-198. PubMed ID: 28259862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
